Patrice Verpillat

Darmstadt, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Corrigendum to "Learnings from a registry-based cohort study for spinal muscular atrophy disease" [Neuromuscular Disorders, Volume 59, February 2026, 106332].

Corrigendum to "Learnings from a registry-based cohort study for spinal muscular atrophy disease" [Neuromuscular Disorders, Volume 59, February 2026, 106332].

Journal: Neuromuscular disorders : NMD

Published: March 28, 2026

Advancing pharmacogenomics in medicines regulation and clinical practice: a call for collaborative action.

Advancing pharmacogenomics in medicines regulation and clinical practice: a call for collaborative action.

Journal: Nature reviews. Drug discovery

Published: November 22, 2025

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Journal: Clinical pharmacology and therapeutics

Published: November 08, 2025

Learnings from a registry-based cohort study for spinal muscular atrophy disease.

Learnings from a registry-based cohort study for spinal muscular atrophy disease.

Journal: Neuromuscular disorders : NMD

Published: June 20, 2025

Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.

Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.

Journal: Clinical pharmacology and therapeutics

Published: December 05, 2024

First-line treatment patterns and overall survival in patients diagnosed with metastatic Merkel cell carcinoma in England from 2013 to 2020: results of a nationwide observational cohort study.

First-line treatment patterns and overall survival in patients diagnosed with metastatic Merkel cell carcinoma in England from 2013 to 2020: results of a nationwide observational cohort study.

Journal: The British journal of dermatology

Published: October 08, 2024

Clinical Evidence 2030.

Clinical Evidence 2030.

Journal: Clinical pharmacology and therapeutics

Published: October 01, 2024

Validation of Mortality Data Sources Compared to the National Death Index in the Healthcare Integrated Research Database.

Validation of Mortality Data Sources Compared to the National Death Index in the Healthcare Integrated Research Database.

Journal: Pragmatic and observational research

Published: September 27, 2024

Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives.

Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives.

Journal: Clinical pharmacology and therapeutics

Published: June 12, 2024

Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU.

Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU.

Journal: Frontiers in medicine

Published: March 28, 2024

Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018.

Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018.

Journal: Pharmacoepidemiology and drug safety

Published: January 31, 2024

Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based study.

Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based study.

Journal: Urologic oncology

Published: January 19, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026